2014 Fiscal Year Final Research Report
Nnew approch to discover the medicinal seeds using the cross-reactivity of monoclonal antibody
Project/Area Number |
24590139
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Drug development chemistry
|
Research Institution | Kyushu University |
Principal Investigator |
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Keywords | monoclonal antimody / cross-reactivity / ELISA / morphine / polyacetylene / papuamine / haliclonadiamine |
Outline of Final Research Achievements |
Cross-reactivity is the reaction against a different but similar antigen. We hypotheses that the recognition site of antibody is equivalent to the receptor domain, and utilizing the cross-reactivity, it makes possible to discover the new structures which possess the equivalent of pharmacophar as a small molecule antigen. We developed the new approach for natural product drug discovery utilizing the cross-reactivity of anti-morphine monoclonal antibody (MAb).
|
Free Research Field |
天然物化学
|